Strategic insights into pharmacogenomics coverage: a theory-informed SWOT analysis of UAE insurance stakeholders’ perspectives
Maram O. Abbas, Azhar T. Rahma, Iffat Elbarazi, Bassam R. Ali, George P. Patrinos, Hana Ghadibah, Fatma Al-Maskari · 2025
Read Strategic insights into pharmacogenomics coverage: a theory-informed SWOT analysis of UAE insurance stakeholders’ perspectives by Maram O. Abbas, Azhar T. Rahma, Iffat Elbarazi, Bassam R. Ali, George P. Patrinos, Hana Ghadibah, Fatma Al-Maskari (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12860024.txt.
Description
Maram Abbas and co-authors explore gene-based prescribing in UAE insurance in a 2025 paper. Pharmacogenomic testing matches drugs to a patient's genes, but cost and coverage slow its spread. Insurers' views in the Emirates were little studied.
The team interviewed twelve insurance managers and mapped their views with a SWOT analysis. Awareness of the testing varied widely. Benefits were recognized, yet cost worries, thin physician and public awareness, and weak infrastructure blocked uptake. Privacy concerns were minor. Participants urged joint efforts to align testing with national health goals and to prove its value for money.
Catalog record
| CREATOR | Maram O. Abbas, Azhar T. Rahma, Iffat Elbarazi, Bassam R. Ali, George P. Patrinos, Hana Ghadibah, Fatma Al-Maskari |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 70 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |